![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Resistance Analyses for Ledipasvir/Sofosbuvir-Containing Regimens in Patients Infected With Chronic HCV Who Have Advanced Liver Disease Or Are Post Liver Transplant (SOLAR-1 and -2 Studies)
|
|
|
Reported by Jules Levin
EASL 2026 April 14-17 Barcelona
Michael Charlton1, Michael Manns2, Hadas Dvory-Sobol3, Evguenia Svarovskaia3, Brian Doehle3, Sarah Arterburn3, Shampa De-Oertel3, Diana M. Brainard3, John G. McHutchison3, Michael D. Miller3, Hongmei Mo3, Nezam Afdhal4, David Mutimer5
1Intermountain Medical Center, Murray, Utah, USA; 2Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; 3Gilead Sciences, Inc., Foster City, California, USA; 4Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; 5NIHR Liver Biomedical Research Unit, Queen Elizabeth Hospital, Birmingham, UK
![EASL1](../images/041916/041916-6/EASL1.gif)
![EASL2](../images/041916/041916-6/EASL2.gif)
![EASL3](../images/041916/041916-6/EASL3.gif)
![EASL4](../images/041916/041916-6/EASL4.gif)
![EASL5](../images/041916/041916-6/EASL5.gif)
![EASL6](../images/041916/041916-6/EASL6.gif)
![EASL7](../images/041916/041916-6/EASL7.gif)
![EASL8](../images/041916/041916-6/EASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|